Noonan Syndrome in A 6-Month-Old Female Infant: A Case Report

Authors

  • Chindy Setia Putri Medical Faculty, Lampung University
  • Ismi Citra Ismail RSUD Dr. H. Abdul Moeloek Provinsi Lampung
  • Epriyan Saputra RSUD Pesawaran

DOI:

https://doi.org/10.53089/medula.v17i2.2035

Keywords:

46 XX karyotype, noonan syndrome, turner

Abstract

Noonan syndrome (NS) is an autosomal dominant genetic disorder with significant phenotypic overlap with Turner syndrome (TS). Given these overlapping physical stigmata, accurate diagnosis requires a comprehensive multisystem clinical evaluation and molecular genetic confirmation, particularly when cytogenetic karyotyping yields normal results. A 6-month-old female infant was referred with an initial suspicion of TS, suspected hydrocephalus, and significant gross motor developmental delay. Physical examination revealed characteristic craniofacial and skeletal phenotypic stigmata mimicking TS, including webbed neck, bilateral microtia, low-set ears, hypertelorism, wide-spaced nipples, and bilateral single palmar creases. Echocardiography showed congenital heart disease consisting of mild pulmonary stenosis and a small atrial septal defect. Brain non-contrast CT scan demonstrated Benign Enlargement of the Subarachnoid Space in Infancy (BESS) with mild ventriculomegaly, ruling out obstructive hydrocephalus. Cytogenetic karyotype analysis revealed a normal 46,XX female karyotype, thereby definitively excluding classic TS (45,X). The combination of physical stigmata overlapping with TS, a normal 46,XX karyotype, and the presence of pulmonary stenosis leads to a strong clinical suspicion of Noonan syndrome (strongly suspected Noonan syndrome). However, because molecular genetic testing has not been performed, the diagnosis of NS in this patient remains a clinical diagnosis. This case highlights the importance of a holistic diagnostic approach to differentiate TS and NS phenotypes. Further molecular genetic testing, such as a Targeted Next-Generation Sequencing (NGS) panel for RASopathy genes (PTPN11, SOS1, KRAS, RAF1) or Whole Exome Sequencing (WES), is highly recommended to identify the specific causative gene mutation and achieve a definitive molecular diagnosis.

References

Sharma L, Winters R, Morales A. Sindrom Noonan. StatPearls Publishing; 2026 Jan. Diakes 1 Juli 2026 di https://www.ncbi.nlm.nih.gov/books/NBK532269/.

Mutmainah I, Nillesen WM, Mundhofir FEP, Winarni TI, Van Der Burgt I, Yntema HG, et al. Paediatrica Indonesiana Case Report Clinical and molecular analysis of Noonan syndrome in Indonesia: a case report. Paediatr Indones. 2016.

Long X, Hu Y, Wu M, Yang L, Jin W, Han X. Global burden and between-country inequalities in Turner syndrome from 1990 to 2021. Acta Obstet Gynecol Scand. 2025;104:2339–54. doi:10.1111/aogs.70082 PubMed PMID: 41201067.

Huang AC, Olson SB, Maslen CL. A review of recent developments in turner syndrome research. Journal of Cardiovascular Development and Disease. MDPI; 2021. doi:10.3390/jcdd8110138 PubMed PMID: 34821691.

Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: mechanisms and management. Nature Reviews Endocrinology. Nature Publishing Group; 2019. p. 601–14. doi:10.1038/s41574-019-0224-4 PubMed PMID: 31213699.

Tigor P Simanjuntak. Sindrom Turner. Majalah Kedokteran FK UKI. 2010;XXVII:15–9.

Fudge EB. Turner syndrome: narrative review of genetics and clinical aspects of management. Pediatric Medicine. AME Publishing Company; 2024. doi:10.21037/pm-22-9

Gravholt CH, Andersen NH, Christin-Maitre S, Davis SM, Duijnhouwer A, Gawlik A, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome Proceedings from the 2023 Aarhus International Turner Syndrome Meeting. In: European Journal of Endocrinology. Oxford University Press; 2024. p. G53–151. doi:10.1093/ejendo/lvae050 PubMed PMID: 38748847.

Turner HE, Johannsen EB, Smyth A, Orchard E, Gravholt CH. Approach to the Patient With Turner Syndrome. Journal of Clinical Endocrinology and Metabolism. Endocrine Society; 2026. p. 268–79. doi:10.1210/clinem/dgaf517 PubMed PMID: 40971503.

Ceran A, Kızılcan Çetin S, Şıklar Z, Özsu E, Berberoğlu M, Aycan Z. Turner syndrome across the lifespan: a 25-year single-center experience from neonatal diagnosis to adult outcomes. Front Endocrinol (Lausanne). 2026;17. doi:10.3389/fendo.2026.1771065

Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan syndrome: Clinical features, diagnosis, and management guidelines. Pediatrics. 2010. p. 746–59. doi:10.1542/peds.2009-3207 PubMed PMID: 20876176.

Bartoszewska E, Chrapkowska A, Zielińska O, Mordalska M, Lizon J, Zalewska Z, et al. Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension. Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI); 2025. doi:10.3390/jcm14217698

Zubair M, Lacerda MP. Genetics, Cytogenetic Testing and Conventional Karyotype. StatPearls Publishing; 2026 Jan-. diakses 20 Juni 2026 di https://www.ncbi.nlm.nih.gov/books/NBK563293/.

Chang YT, Hong SY, Lin W De, Lin CH, Lin SS, Tsai FJ, et al. Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics. Children. MDPI; 2023. doi:10.3390/children10030556

Accogli A, Geraldo AF, Piccolo G, Riva A, Scala M, Balagura G, et al. Diagnostic Approach to Macrocephaly in Children. Frontiers in Pediatrics. Frontiers Media S.A.; 2022. doi:10.3389/fped.2021.794069

DYSCERNE Noonan Syndrome Guideline Development Group. Noonan Syndrome Clinical Management Guidelines Management of Noonan Syndrome A Clinical Guideline. University of Manchester. 2011.

Murdock DR, Donovan FX, Chandrasekharappa SC, Banks N, Bondy C, Muenke M, et al. Whole-Exome sequencing for diagnosis of turner syndrome: Toward next-generation sequencing and newborn screening. Journal of Clinical Endocrinology and Metabolism. 2017;102:1529–37. doi:10.1210/jc.2016-3414 PubMed PMID: 28324009.

Noonan Syndrome Neha Sekhri, Genetic Counseling Intern INTRODUCTION [Internet]. 2009. Available from: http://www.peds.ufl.edu/divisions/genetics/

Lee PA, Ross JL, Pedersen BT, Kotnik P, Germak JA, Christesen HT. Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program. Int J Pediatr Endocrinol. 2015;2015. doi:10.1186/s13633-015-0015-1

Published

2026-07-30

How to Cite

Putri, C. S., Ismail, I. C., & Saputra, E. (2026). Noonan Syndrome in A 6-Month-Old Female Infant: A Case Report. Medical Profession Journal of Lampung, 17(2), 1-8. https://doi.org/10.53089/medula.v17i2.2035

Issue

Section

Artikel